Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Microbiota Analysis With Next-generation 16S rRNA Gene Sequencing in IAI Patients With Sepsis-associated Liver Dysfunction

NCT05628493 is registered in ClinicalTrials.gov with Chinese Medical Association as lead sponsor.

NCT NCT05628493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05628493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Microbiota Analysis With Next-generation 16S rRNA Gene Sequencing in IAI Patients With Sepsis-associated Liver Dysfunction
Lead sponsor
Chinese Medical Association
Phase
Observational
Overall status
Completed
Start date
January 3, 2022
Completion date
September 14, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute gastrointestinal injury, gut microbiota, intra-abdominal infections, sepsis-associated liver dysfunction